With regards to health and safety, INALCA’s efforts focused on extending the OHSAS 18001 certification standard to the four INALCA establishments in Italy. This result was completed in the autumn of 2015 with the certification of the Capo d’Orlando (ME) plant, crowning an activity started in 2013. By 2017, the extension of the aforementioned certification is foreseen for the newly acquired Pegognaga (Mn) plant.

Scheletric muscle
pathology prevention project

INALCA together with the University of Bologna carry out a project to analyse the statistical distribution of skeletal muscle disorders within the company employee of the Inalca plant in Modena. Through detailed clinical analysis of employees, numerous data related to these pathologies were collected. The processing of this data will be taken into account for the overall assessment of the employees’ situation, possible areas of improvement and possible organisational solutions to reduce worker exposure to this type of risk.

ANT – Melanoma project

INALCA, in collaboration with ANT, joined the “Melanoma” project dedicated to primary prevention and early diagnosis of this disease. The project provides free dermatological visits for INALCA employees. The goal of the project is to provide employees with the appropriate knowledge and awareness about the prevention of skin cancer and to facilitate preventive action.